0 CHECKOUT

PRODUCT FILTERS

REGION

35
23
16
14
14

COUNTRY

9
5
4
3
3

CATEGORIES

  • 24
  • 14
  • 11
  • 10
  • 10
  • 10
  • 9
  • 8
  • 7
  • 6
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

38
42
44
114

PUBLISHED

1
17
27
114

PRODUCT TYPE

72
41
1

Search for: "Molecular Epidemiology of Chronic Diseases - DUPLICATE"

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

Published:  January 2016
Price:  From

Molecular Epidemiology of Chronic Diseases

"I think this is an excellent book–I recommend it to anyone involved in molecular epidemiology... The 26 chapters are written by topic specialists, in an explanatory, east to read style." –BTS Newsletter,...

Published:  April 2008
Price: 

Animal Biotechnology - Technologies, Markets and Companies

This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important...

Published:  January 2016
Price:  From

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

Published:  January 2016
Price:  From

Pain Therapeutics - Drugs, Markets and Companies

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic...

Published:  January 2016
Price:  From

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

Published:  January 2016
Price:  From

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

Published:  January 2016
Price:  From

Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) - Identifying and Commercializing First-in-Class Innovation Summary Chronic Obstructive Pulmonary Disease (COPD) is a progressive...

Published:  December 2015
Price:  From

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

Published:  January 2016
Price:  From

Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth

Global Immunology Market to 2022 - Large pipeline and competitive market to drive long-term market growth Summary Immune-mediated inflammatory diseases are a very common set of chronic disorders...

Published:  December 2015
Price:  From

Type 2 Diabetes Mellitus Therapeutics in Asia-Pacific Markets to 2021 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination...

Published:  January 2016
Price:  From

Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation

Large and Innovative Pipeline: Analysis has confirmed the asthma pipeline to be highly active, with 252 products in active development across all stages. The range of mechanisms of action employed...

Published:  May 2015
Price:  From

Winning Strategies in Molecular Diagnostics: Integrating New Technology Planning with Business and Corporate Strategies--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

This new seven-country study from the author contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities...

Published:  June 2014
Price:  From

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

Published:  January 2016
Price:  From

Future Horizons and Growth Strategies in the US Molecular Diagnostics Market 2014: Supplier Shares and Country Forecasts

This new 880-page report from the author contains 37 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including: Major issues pertaining to the US molecular diagnostics...

Published:  August 2014
Price:  From

Next Generation Sequencing (Genome/Exome sequencing/DNA sequencing) Global market - Forecast to 2020

Next Generation Sequencing (NGS) enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes capable of producing hundreds of gigabases of data in a single sequencing run....

Published:  November 2014
Price:  From

2014-2014 UK Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides...

Published:  November 2014
Price:  From

2014-2014 German Hepatitis Markers Testing Market: Hospitals, Blood Banks, Commercial Labs--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

The report presents a detailed analysis of the Hepatitis diagnostics market in Germany. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides...

Published:  November 2014
Price:  From

2014-2014 US Hepatitis Markers Testing Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides...

Published:  November 2014
Price:  From

2015-2019 France Hepatitis Markers Testing Market: Hospitals, Blood Banks, Commercial Labs--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides...

Published:  September 2015
Price:  From
Loading Indicator

Our Clients

  • Goodyear Tire & Rubber Company
  • GlaxoSmithKline PLC
  • Hilton Worldwide
  • Hewlett-Packard Company
  • Accenture PLC.
  • Qualcomm Incorporated
  • UBS AG